{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:17:24Z","timestamp":1783977444642,"version":"3.55.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific and Technological Innovation 2030-Major Project","award":["2024ZD0523400"],"award-info":[{"award-number":["2024ZD0523400"]}]},{"name":"Major Program of Health Science and Technology of Guangzhou","award":["2024A031007"],"award-info":[{"award-number":["2024A031007"]}]},{"name":"Innovation Team Project of Guangdong General Colleges and Universities","award":["2022KCXTD003"],"award-info":[{"award-number":["2022KCXTD003"]}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82104705"],"award-info":[{"award-number":["82104705"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2023M741603"],"award-info":[{"award-number":["2023M741603"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-025-10128-1","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T22:04:29Z","timestamp":1765404269000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["From bioinformatics to clinical translation: BIRC5 as a pivotal diagnostic biomarker and therapeutic target for NAFLD-driven HCC"],"prefix":"10.1007","volume":"42","author":[{"given":"Yushu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"issue":"1","key":"10128_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06167-1","volume":"23","author":"Q An","year":"2025","unstructured":"An Q, et al. Role of CD4(+) T cells in cancer immunity: a single-cell sequencing exploration of tumor microenvironment. J Transl Med. 2025;23(1):179.","journal-title":"J Transl Med"},{"issue":"7","key":"10128_CR2","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.2174\/1871520621666210623093550","volume":"22","author":"P Aytac","year":"2022","unstructured":"Aytac P, Sahin ID, Atalay RC, Tozkoparan B. Design, synthesis and biological evaluation of novel triazolothiadiazoles derived from NSAIDs as anticancer agents. Anticancer Agents Med Chem. 2022;22(7):1340\u20137.","journal-title":"Anticancer Agents Med Chem"},{"issue":"1","key":"10128_CR3","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/SLA.0000000000001894","volume":"266","author":"AS Bodzin","year":"2017","unstructured":"Bodzin AS, Lunsford KE, Markovic D, Harlander-Locke MP, Busuttil RW, Agopian VG. Predicting mortality in patients developing recurrent hepatocellular carcinoma after liver transplantation impact of treatment modality and recurrence characteristics. Ann Surg. 2017;266(1):118\u201325.","journal-title":"Ann Surg"},{"key":"10128_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.canlet.2020.12.019","volume":"502","author":"J Chen","year":"2021","unstructured":"Chen J, et al. Acsl4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc\/SREBP1 pathway. Cancer Lett. 2021;502:154\u201365.","journal-title":"Cancer Lett"},{"key":"10128_CR5","first-page":"1","volume":"149","author":"S Chidambaranathan-Reghupaty","year":"2021","unstructured":"Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D. Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv Cancer Res. 2021;149:1\u201361.","journal-title":"Adv Cancer Res"},{"issue":"14","key":"10128_CR6","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.3390\/cancers15143723","volume":"15","author":"J Fang","year":"2023","unstructured":"Fang J, Celton-Morizur S, Desdouets C. Nafld-related HCC: focus on the latest relevant preclinical models. Cancers (Basel). 2023;15(14):3723.","journal-title":"Cancers (Basel)"},{"key":"10128_CR7","unstructured":"Ferlay J, Ervik M, Lam F, et al editors.\u00a0Global cancer observatory: cancer today (version 1.0). International Agency for Research on Cancer; 2024.\u00a0https:\/\/gco.iarc.who.int\/today.\u00a0Accessed 1 Feb 2024."},{"issue":"3","key":"10128_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/liv.14735","volume":"41","author":"F Garuti","year":"2021","unstructured":"Garuti F, et al. The changing scenario of hepatocellular carcinoma in Italy: an update. Liver Int. 2021;41(3):585\u201397.","journal-title":"Liver Int"},{"issue":"16","key":"10128_CR9","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1038\/onc.2015.264","volume":"35","author":"J Hagenbuchner","year":"2016","unstructured":"Hagenbuchner J, Kiechl-Kohlendorfer U, Obexer P, Ausserlechner MJ. BIRC5\/survivin as a target for glycolysis inhibition in high-stage neuroblastoma. Oncogene. 2016;35(16):2052\u201361.","journal-title":"Oncogene"},{"issue":"6","key":"10128_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13760","volume":"17","author":"Z Huang","year":"2024","unstructured":"Huang Z, et al. The adiponectin-derived peptide ALY688 protects against the development of metabolic dysfunction-associated steatohepatitis. Clin Transl Sci. 2024;17(6):e13760.","journal-title":"Clin Transl Sci"},{"issue":"23","key":"10128_CR11","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.3390\/ijms232315002","volume":"23","author":"AG Izquierdo","year":"2022","unstructured":"Izquierdo AG, et al. Gender dimorphism in hepatic carcinogenesis-related gene expression associated with obesity as a low-grade chronic inflammatory disease. Int J Mol Sci. 2022;23(23):15002.","journal-title":"Int J Mol Sci."},{"issue":"1","key":"10128_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.439","volume":"8","author":"L Ju","year":"2017","unstructured":"Ju L, et al. Enhanced expression of survivin has distinct roles in adipocyte homeostasis. Cell Death Dis. 2017;8(1):e2533.","journal-title":"Cell Death Dis"},{"issue":"2","key":"10128_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.ccell.2020.05.018","volume":"38","author":"Y Kudo","year":"2020","unstructured":"Kudo Y, et al. PKClambda\/iota loss induces autophagy, oxidative phosphorylation, and NRF2 to promote liver cancer progression. Cancer Cell. 2020;38(2):247-262.e11.","journal-title":"Cancer Cell"},{"issue":"8","key":"10128_CR14","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.3390\/cells10081901","volume":"10","author":"HY Lee","year":"2021","unstructured":"Lee HY, Nga HT, Tian J, Yi HS. Mitochondrial metabolic signatures in hepatocellular carcinoma. Cells. 2021;10(8):1901.","journal-title":"Cells."},{"issue":"40","key":"10128_CR15","doi-asserted-by":"publisher","first-page":"13737","DOI":"10.1074\/jbc.RA120.013805","volume":"295","author":"K Li","year":"2020","unstructured":"Li K, Liu T, Chen J, Ni H, Li W. Survivin in breast cancer-derived exosomes activates fibroblasts by up-regulating SOD1, whose feedback promotes cancer proliferation and metastasis. J Biol Chem. 2020;295(40):13737\u201352.","journal-title":"J Biol Chem"},{"key":"10128_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1509342","volume":"15","author":"G Li","year":"2024","unstructured":"Li G, et al. BIRC5 as a prognostic and diagnostic biomarker in pan-cancer: an integrated analysis of expression, immune subtypes, and functional networks. Front Genet. 2024;15:1509342.","journal-title":"Front Genet"},{"key":"10128_CR17","doi-asserted-by":"publisher","first-page":"1363695","DOI":"10.3389\/fonc.2024.1363695","volume":"14","author":"Y Lu","year":"2024","unstructured":"Lu Y, Lin B, Li M. The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma. Front Oncol. 2024;14:1363695.","journal-title":"Front Oncol."},{"issue":"6","key":"10128_CR18","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jiph.2019.03.015","volume":"12","author":"Y Luo","year":"2019","unstructured":"Luo Y, Liu T, Fei W, Yue X. Correlation between SOX2 and survivin clinical features in patients with salivary adenoid cystic carcinoma. J Infect Public Health. 2019;12(6):847\u201353.","journal-title":"J Infect Public Health"},{"issue":"1","key":"10128_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-01592-y","volume":"15","author":"Y Mai","year":"2024","unstructured":"Mai Y, Ji Z, Tan Y, Feng L, Qin J. BIRC5 knockdown ameliorates hepatocellular carcinoma progression via regulating PPARgamma pathway and cuproptosis. Discov Oncol. 2024;15(1):706.","journal-title":"Discov Oncol"},{"issue":"1","key":"10128_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-022-03675-2","volume":"20","author":"Z Mo","year":"2022","unstructured":"Mo Z, et al. Single-cell transcriptomics reveals the role of macrophage-naive CD4 + T cell interaction in the immunosuppressive microenvironment of primary liver carcinoma. J Transl Med. 2022;20(1):466.","journal-title":"J Transl Med"},{"issue":"1","key":"10128_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/0113892029273682240111052317","volume":"25","author":"R Mu","year":"2024","unstructured":"Mu R, et al. Analysis of the expression of PRDX6 in patients with hepatocellular carcinoma and its effect on the phenotype of hepatocellular carcinoma cells. Curr Genomics. 2024;25(1):2\u201311.","journal-title":"Curr Genomics"},{"issue":"7854","key":"10128_CR22","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","volume":"592","author":"D Pfister","year":"2021","unstructured":"Pfister D, et al. NASH limits anti-tumour surveillance in immunotherapy-treated HCC. Nature. 2021;592(7854):450\u20136.","journal-title":"Nature"},{"key":"10128_CR23","doi-asserted-by":"crossref","unstructured":"Ram Makena, M., Gatla, H., Verlekar, D., Sukhavasi, S., K Pandey, M. and C Pramanik, K., 2019. Wnt\/beta-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance. Int J Mol Sci 20 (17).","DOI":"10.3390\/ijms20174242"},{"issue":"6","key":"10128_CR24","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77(6):1598\u2013606.","journal-title":"J Hepatol"},{"issue":"1","key":"10128_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-90884-6","volume":"15","author":"I Seven","year":"2025","unstructured":"Seven I, et al. Predicting hepatocellular carcinoma survival with artificial intelligence. Sci Rep. 2025;15(1):6226.","journal-title":"Sci Rep"},{"issue":"2","key":"10128_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2024.102446","volume":"15","author":"SP Singh","year":"2025","unstructured":"Singh SP, Madke T, Chand P. Global epidemiology of hepatocellular carcinoma. J Clin Exp Hepatol. 2025;15(2):102446.","journal-title":"J Clin Exp Hepatol"},{"issue":"8","key":"10128_CR27","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1002\/jcp.30276","volume":"236","author":"M Vaghari-Tabari","year":"2021","unstructured":"Vaghari-Tabari M, Ferns GA, Qujeq D, Andevari AN, Sabahi Z, Moein S. Signaling, metabolism, and cancer: an important relationship for therapeutic intervention. J Cell Physiol. 2021;236(8):5512\u201332.","journal-title":"J Cell Physiol"},{"issue":"3","key":"10128_CR28","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","volume":"42","author":"Y Wang","year":"2023","unstructured":"Wang Y, Deng B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer Metastasis Rev. 2023;42(3):629\u201352.","journal-title":"Cancer Metastasis Rev"},{"issue":"6","key":"10128_CR29","doi-asserted-by":"publisher","first-page":"368","DOI":"10.2174\/0113892029277262231108105441","volume":"24","author":"Y Xiong","year":"2023","unstructured":"Xiong Y, et al. Aberrant expressions of PSMD14 in tumor tissue are the potential prognostic biomarkers for hepatocellular carcinoma after curative resection. Curr Genomics. 2023;24(6):368\u201384.","journal-title":"Curr Genomics"},{"issue":"1","key":"10128_CR30","doi-asserted-by":"publisher","DOI":"10.1515\/med-2024-1007","volume":"19","author":"W Xu","year":"2024","unstructured":"Xu W, et al. Decreased BIRC5-206 promotes epithelial-mesenchymal transition in nasopharyngeal carcinoma through sponging miR-145-5p. Open Med. 2024;19(1):20241007.","journal-title":"Open Med"},{"issue":"2","key":"10128_CR31","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jhep.2023.02.033","volume":"79","author":"N Yahoo","year":"2023","unstructured":"Yahoo N, Dudek M, Knolle P, Heikenwalder M. Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation. J Hepatol. 2023;79(2):538\u201351.","journal-title":"J Hepatol"},{"issue":"4","key":"10128_CR32","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/imm.13853","volume":"173","author":"Y Yang","year":"2024","unstructured":"Yang Y, et al. Hypoxic tumour-derived exosomal miR-1290 exacerbates the suppression of CD8+ T cells by promoting M2 macrophage polarization. Immunology. 2024;173(4):672\u201388.","journal-title":"Immunology"},{"issue":"8","key":"10128_CR33","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.21037\/jtd-2025-216","volume":"17","author":"S Yang","year":"2025","unstructured":"Yang S, et al. BIRC5 expression correlates with immunosuppressive phenotype and predicts inferior response to immunotherapy in lung adenocarcinoma. J Thorac Dis. 2025;17(8):5921\u201335.","journal-title":"J Thorac Dis"},{"issue":"43","key":"10128_CR34","doi-asserted-by":"publisher","first-page":"7546","DOI":"10.3748\/wjg.v27.i43.7546","volume":"27","author":"J Yu","year":"2021","unstructured":"Yu J, Wang Z, Zhang H, Wang Y, Li DQ. Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma. World J Gastroenterol. 2021;27(43):7546\u201362.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10128_CR35","first-page":"1658","volume":"10","author":"T Zhang","year":"2020","unstructured":"Zhang T, et al. Neoadjuvant therapy and immunotherapy strategies for hepatocellular carcinoma. Am J Cancer Res. 2020;10(6):1658\u201367.","journal-title":"Am J Cancer Res"},{"key":"10128_CR36","doi-asserted-by":"publisher","DOI":"10.1177\/09636897211008874","volume":"30","author":"M Zhang","year":"2021","unstructured":"Zhang M, Yan X, Wen P, Bai W, Zhang Q. Circankrd52 pr","journal-title":"Cell Transplant"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10128-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-025-10128-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-025-10128-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T01:27:56Z","timestamp":1770859676000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-025-10128-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10128"],"URL":"https:\/\/doi.org\/10.1007\/s10565-025-10128-1","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]},"assertion":[{"value":"15 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The clinical component of this study was approved by the Ethics Committee of Nanfang Hospital of Southern Medical University (Approval Number: NFEC-2019\u2013064), with written informed consent obtained from all participants. Animal experiments were authorized by the Animal Ethics Committee of The Experimental Animal Ethics Committee of Guangdong Academy of Sciences (Approval Number: K2024-01\u2013179-497) and performed in compliance with the Declaration of Helsinki and the Guide for the Care and Use of Laboratory Animals. All procedures were designed to adhere to ethical principles of animal welfare and human research protection. The data used in this study were retrieved from public databases TCGA and GEO. All datasets were obtained in accordance with the database\u00a0\u2019s access policies, and the original studies associated with these datasets have been approved by their respective ethical committees.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"32"}}